Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:28:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice was added about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:36:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:39:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:45:42.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study details page now shows a 403 Forbidden error instead of the expected content. This blocks access to the NCT02530463 study details.
    Difference
    0.5%
    Check dated 2026-09-27T19:35:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, blocking access to the study details. The additions include a 403 notice and a revision snippet (Revision: v3.7.0).
    Difference
    23%
    Check dated 2026-09-20T20:10:17.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.